MedPath

Acorai Machine Learning Generalization (MLG) Study

Completed
Conditions
Heart Failure
Interventions
Device: Acorai Sensor Data Collection (ASDC) system 1.0 - Phase 1
Device: Acorai Sensor Data Collection (ASDC) system 1.0 - Phase 2
Registration Number
NCT05835024
Lead Sponsor
Acorai AB
Brief Summary

Acorai is developing a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters in patients with suspected or confirmed heart failure, and/or pulmonary hypertension, who require hemodynamic assessment. The device will be intended as a companion test or clinical decision support tool to be used and interpreted by qualified healthcare professionals to aid standard-of-care clinical assessment in identifying hemodynamic congestion and supporting personalized treatment of heart failure and pulmonary congestion.

This study is part of the development of a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters. It will be conducted to collect the data needed to train the machine learning models retrospectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1602
Inclusion Criteria
  • Subject is, at least, 18 years of age at the time of screening visit.
  • Subject is willing and physically able to comply with the specified evaluations as per the clinical investigation plan, as assessed by the investigator.
  • Subject is referred for invasive hemodynamic assessment with right heart cardiac catheterization.
  • Patient has provided written informed consent using the Ethics Committee/ Institutional Review Board approved consent form.
Exclusion Criteria
  • Discretionary exclusion when, in the opinion of the investigator, the inclusion of a potential subject is not in their best interest or not in the interest of compliant performance of the clinical investigation.
  • Subjects who are pregnant are excluded in the US

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Participants phase 1Acorai Sensor Data Collection (ASDC) system 1.0 - Phase 1Phase 1: patients enrolled for a right heart catheterization procedure as part of their standard of care.
Participants phase 2Acorai Sensor Data Collection (ASDC) system 1.0 - Phase 2Phase 2: patients enrolled for a right heart catheterization procedure as part of their standard of care.
Primary Outcome Measures
NameTimeMethod
Evaluation of the ML's performance to estimate pressureDay 0 to Day 90

Performance of the ML model trained on data collected from the ASDC System to estimate left-sided filling pressure compared to right heart catheterization.

Secondary Outcome Measures
NameTimeMethod
Diagnostic accuracy of ML modelDay 0 to Day 90

The diagnostic accuracy of the ML model trained on data collected from the ASDC System to detect clinically significant abnormal right heart catheterization measurements.

Evaluation of the ML's performance to estimate other hemodynamic parametersDay 0 to Day 90

The performance of the ML model trained on data collected from the ASDC System to estimate other hemodynamic parameters (such as right atrial pressure) compared to right heart catheterization.

Trial Locations

Locations (18)

Conway Regional Cardiovascular Clinic

πŸ‡ΊπŸ‡Έ

Conway, Arkansas, United States

Baptist Health Medical Centre

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

Mayo Clinic

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

Cleveland Clinic Martin Health

πŸ‡ΊπŸ‡Έ

Stuart, Florida, United States

Saint Luke's Hospital of Kansas City

πŸ‡ΊπŸ‡Έ

Kansas City, Missouri, United States

WakeMed

πŸ‡ΊπŸ‡Έ

Raleigh, North Carolina, United States

University of Pennsylvania

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Medical University of South Carolina (MUSC)

πŸ‡ΊπŸ‡Έ

Charleston, South Carolina, United States

Austin Heart Central and San Marcos

πŸ‡ΊπŸ‡Έ

Austin, Texas, United States

Austin Heart Round Rock

πŸ‡ΊπŸ‡Έ

Austin, Texas, United States

Onze-Lieve-Vrouwziekenhuis (OLV) Hospital Aalst

πŸ‡§πŸ‡ͺ

Aalst, Belgium

University of Ottawa Heart Institute

πŸ‡¨πŸ‡¦

Ottawa, Canada

Mount Sinai Hospital Toronto

πŸ‡¨πŸ‡¦

Toronto, Canada

Toronto General Hospital

πŸ‡¨πŸ‡¦

Toronto, Canada

Rigshospitalet, University Hospital of Copenhagen

πŸ‡©πŸ‡°

Copenhagen, Denmark

Sahlgrenska university hospital

πŸ‡ΈπŸ‡ͺ

Gothenburg, Sweden

Royal Brompton and Harefield Hospitals

πŸ‡¬πŸ‡§

London, United Kingdom

Southampton University Hospital

πŸ‡¬πŸ‡§

Southampton, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath